Prior to the financial crisis of 2008/09, it was widely believed in the stock market that certain sectors – most notably utilities, pharmaceuticals, food retailing and tobacco – were far less vulnerable to market downturns.
02 May 2018
The Monthly
Time Finance plc (TIME:LON), 25.0 | Abzena (ABZA:LON), 0 | Advanced Oncotherapy Plc (AVO:LON), 43.5 | Allergy Therapeutics plc (AGY:LON), 19.8 | Alliance Pharma plc (APH:LON), 88.0 | Arbuthnot Banking Group PLC (ARBB:LON), 875 | Avacta Group PLC (AVCT:LON), 136 | Bionomics Ltd (BNO:ASX), 0 | Burford Capital Limited (BUR:LON), 668 | Chamberlin plc (CMH:LON), 7.0 | City of London Investment Group PLC (CLIG:LON), 464 | Diurnal Group plc (DNL:LON), 58.0 | Evgen Pharma Plc (EVG:LON), 10.6 | Gateley (Holdings) Plc (GTLY:LON), 168 | Genedrive Plc (GDR:LON), 40.0 | Inland Homes PLC (INL:LON), 58.0 | Koovs (KOOV:LON), 0 | Morses Club Plc (MCL:LON), 60.1 | Murgitroyd Group (MUR:LON), 0 | Non-Standard Finance Plc (NSF:LON), 3.6 | Yourgene Health Plc (YGEN:LON), 14.2 | Primary Health Properties PLC (PHP:LON), 147 | R.E.A. Holdings plc (RE:LON), 57.2 | Redx Pharma Plc (REDX:LON), 57.5 | Scancell Holdings Plc (SCLP:LON), 15.2 | Surface Transforms plc (SCE:LON), 68.5 | 600 Group PLC (SIXH:LON), 8.4 | Tissue Regenix Group plc (TRX:LON), 0.5 | Titon Holdings Plc (TON:LON), 110 | Oxford BioMedica plc (OXB:LON), 936
-
-
-
Mark Thomas
-
48 pages
-


Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
The Monthly
Time Finance plc (TIME:LON), 25.0 | Abzena (ABZA:LON), 0 | Advanced Oncotherapy Plc (AVO:LON), 43.5 | Allergy Therapeutics plc (AGY:LON), 19.8 | Alliance Pharma plc (APH:LON), 88.0 | Arbuthnot Banking Group PLC (ARBB:LON), 875 | Avacta Group PLC (AVCT:LON), 136 | Bionomics Ltd (BNO:ASX), 0 | Burford Capital Limited (BUR:LON), 668 | Chamberlin plc (CMH:LON), 7.0 | City of London Investment Group PLC (CLIG:LON), 464 | Diurnal Group plc (DNL:LON), 58.0 | Evgen Pharma Plc (EVG:LON), 10.6 | Gateley (Holdings) Plc (GTLY:LON), 168 | Genedrive Plc (GDR:LON), 40.0 | Inland Homes PLC (INL:LON), 58.0 | Koovs (KOOV:LON), 0 | Morses Club Plc (MCL:LON), 60.1 | Murgitroyd Group (MUR:LON), 0 | Non-Standard Finance Plc (NSF:LON), 3.6 | Yourgene Health Plc (YGEN:LON), 14.2 | Primary Health Properties PLC (PHP:LON), 147 | R.E.A. Holdings plc (RE:LON), 57.2 | Redx Pharma Plc (REDX:LON), 57.5 | Scancell Holdings Plc (SCLP:LON), 15.2 | Surface Transforms plc (SCE:LON), 68.5 | 600 Group PLC (SIXH:LON), 8.4 | Tissue Regenix Group plc (TRX:LON), 0.5 | Titon Holdings Plc (TON:LON), 110 | Oxford BioMedica plc (OXB:LON), 936
- Published:
02 May 2018 -
Author:
Mark Thomas -
Pages:
48 -
Prior to the financial crisis of 2008/09, it was widely believed in the stock market that certain sectors – most notably utilities, pharmaceuticals, food retailing and tobacco – were far less vulnerable to market downturns.